NASDAQ:ALGS | Operating Income | Aligos Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2019-09-30 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$1.89M
2026-03-31-$26.93M
2025-12-31-$21.81M
2025-09-30-$28.36M
2025-06-30-$18.57M
2025-03-31-$19.24M
2024-12-31-$20.56M
2024-09-30-$20.13M
2024-06-30-$26.41M
2024-03-31-$22.05M
2023-12-31-$26M
2023-09-30-$19.07M
2023-06-30-$19.14M
2023-03-31-$23.92M
2022-12-31-$22.68M
2022-09-30-$18.95M
2022-06-30-$20.39M
2022-03-31-$35.56M
2021-12-31-$37.95M
2021-09-30-$33.07M
2021-06-30-$29.57M
2021-03-31-$27.74M
2020-12-31-$34.29M
2020-09-30-$21.56M
2020-06-30-$21.27M
2020-03-31-$20.72M
2019-12-31-$18.44M
2019-09-30-$14.5M

Annual Operating Income

DateOperating Income
2025-12-31-$87.99M
2024-12-31-$89.15M
2023-12-31-$88.13M
2022-12-31-$97.58M
2021-12-31-$128.32M
2020-12-31-$97.83M
2019-12-31-$54.04M